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Abstract In this study we examined the role of rho p21 in neuropeptide-stimulated tyrosine phosphorylation. I tact Swiss 3T3 cells were treated 
with the Clostridium botulinum C3 exoenzyme which specifically ADP ribosylates and inactivates rho ~21. C3 exoenzyme tr atment of cells caused 
a marked ecrease in both bombesm- and endotherm-stimulated tyrosine phosphorylation of multiple proteins, including ~125 focal adhesion kinase 
(FAK) and paxillin. Our results suggest that rho p21 is a component ofthe signal transduction pathway linking seven transmembrane domain receptors 
with tyrosme phosphorylation a d cytoskeletal events. 
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1. Introduction 
Tyrosine phosphorylation has recently been implicated in the 
intracellular signaling of neuropeptides that act as potent cellu- 
lar growth factors through seven transmembrane domain re- 
ceptors [ 1,2]. Bombesin and other neuropeptide growth factors 
stimulate tyrosine phosphorylation of multiple proteins in 
Swiss 3T3 cells, including broad bands of A4, 1 lO,OOO-130,000 
and 70,000-80,000 [3-6]. Recently the focal adhesion associated 
proteins ~125 focal adhesion kinase @12SFAK), a novel tyrosine 
kinase [7,8], and paxillin [9,10] have been identified as promi- 
nent tyrosine-phosphorylated proteins in Swiss 3T3 cells 
stimulated by bombesin and other neuropeptides [11,12]. The 
rapidity of neuropeptide-stimulated tyrosine phosphorylation 
is consistent with ~125~~~ and paxillin functioning in a neu- 
ropeptide-activated tyrosine kinase pathway. However, the 
components of this pathway have not been fully identified. 
The increases in p125FAK and paxillin tyrosine phosphoryla- 
tion are accompanied by a profound reorganisation of the actin 
cytoskeleton and by the assembly of focal adhesion plaques, the 
distinct sites on the plasma membrane where both ~125~~ and 
paxillin are localised [13,14]. Studies utilising cytochalasin D, 
which selectively disrupts the network of actin filaments, dem- 
onstrated that bombesin-stimulated tyrosine phosphorylation 
of ~125~~~ and paxillin is dependent on the integrity of the 
actin cytoskeleton [12,13]. The rho gene products (rho p21s), 
which are members of the ras superfamily of small GTP-bind- 
ing proteins, have been implicated in mitogen-stimulated for- 
mation of focal adhesions and actin stress fibers [ 151. The func- 
tion of rho p21 is specifically impaired by treatment with the 
Clostridium botulinurn C3 exoenzyme, which ADP ribosylates 
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the Asn4’ of rho p21 and thereby prevents its interaction with 
downstream targets [l&l 81. 
Here we report that bombesin- and endothelin-stimulated 
tyrosine phosphorylation of multiple proteins, including 
~125~~ and paxillin is markedly inhibited by treatment with 
botulinum C3 exoenzyme. The results imply that rho p21 lies 
upstream of the tyrosine phosphorylation events in a neuropep- 
tide-stimulated signal transduction pathway. 
2. Materials and methods 
2.1. Materials 
Bombesm, tetramethylrhodamine B isothiocyanate (TRITC)-conju- 
gated phalloidin, fluorescein sothiocyanate (FITC)-linked anti-mouse 
IgG agarose-linked anti-mouse IgG were obtained from Sigma. Anti- 
Tyr(P) monoclonal ntibody (mAb), clone Py72, was obtained from the 
hybridoma development unit, Imperial Cancer Research Fund, Lon- 
don, UK. Py20 anti-Tyr(P) mAb and the mAb directed against paxillin 
(mAb165) were from ICN, High Wycombe, UK. 4GlO anti-Tyr(P) 
mAb, mAb 2A7 directed against ~125~~ were from TCS Biologicals 
Ltd., Buckingham, UK. Anti-p125FAK mAb for Western blotting was 
obtained from AFFINITI Research Products L d., Nottingham, UK. 
‘*sI-Labelled sheep anti-mouse IgG (50 &i/mg) and carrier-free ‘*Pi 
were from Amersham, UK. All other eagents used were of the purest 
grade available. 
2.2. Preparation of recombinant C3 exoenzyme 
The C3 exoenzyme gene [17] was modified by PCR-mediated site- 
directed mutagenesis to produce a recombinant C3 exoenzyme that 
lacks the signal peptide and has the dipeptide Met-Ala attached to Ser 
of the mature exoenzyme. PCR was performed with the cloned gene as 
the template and with the synthetic oligonucleotides (5’-ACTGTTCA- 
TATGGCTAGCTATGCAGATACFITC-ACA-3’ and S-TTATTG- 
GATCCTATTATTT’AAATATCATTGCTGTAA-3’) as primers. The 
amplified fragment was cleaved with NdeI and BarnHI and ligated with 
a PET-3a vector [19]. After confirming the DNA sequence, the recom- 
binant plasmid, PET-3&3 was introduced into Escherichia coli BL21 
(DE3)pLysE and expressed [17,19,20]. 
2.3. Cell culture and C3 exoenzyme pretreatment 
Swiss 3T3 cells were seeded at a density of 1 x lo5 per 30 mm dish 
in 2 ml of Dulbecco’s modified Eagle’s medium (DMEM) supple- 
mented with 10% fetal bovine serum. At 72 h, recombinant C3 exoen- 
zyme at a final concentration of 7.5 &ml or diluent was added to the 
medium. After being cultured for a further 48 h the cells were washed 
twice with DMEM and then incubated in DMEMlWaymouths (1: 1, 
v/v) in the presence or absence of C3 exoenzyme at 15 &ml for 24 h. 
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This protocol has previously been shown to ADP ribosylate rho p21 in 
intact Swiss 3T3 cells, as shown by the fact that cell homogenates from 
C3 exoenzyme-treated cells contain markedly reduced levels of native 
rho p21 available for [‘2P]ADP ribosylation by externally added C3 
exoenzyme (data not shown) [21,22]. 
2.4. Immunoprecipitations 
Control and C3 exoenzyme pretreated cultures of Swiss 3T3 cells 
(l-2 x 106) were challenged with bombesin or endothelin for the times 
indicated and lysed at 4°C in 1 ml of a solution containing 10 mM 
Tris-HCl, pH 7.6, 5 mM EDTA, 50 mM NaCI, 30 mM sodium pyro- 
phosphate, 50 mM NaF, 100 mM Na,VO, and 1% Triton X-100 (lysis 
buffer). Lysates were clarified by centrifugation at 15,000 x g for 10 min 
and precleared by incubation with albumin-agarose for 1 h at 4°C. 
After removal of albumin-agarose by brief (10 s) centrifugation, the 
supematants were transferred to fresh tubes for immunoprecipitation. 
Proteins were immunoprecipitated at4°C for 4 h with anti-mouse IgG 
agarose-linked mAbs directed against either phosphotyrosine (Py 72), 
~125~~~ (mAb 2A7) or paxillin (mAb 165) as indicated. Immunoprecip- 
itates were washed three times with lysis buffer and extracted for 10 min 
at 95°C in 2 x SDS-PAGE sample buffer (200 mM Tris-HCl, 6% SDS, 
2 mM EDTA, 4% 2-mercaptoethanol, 10% glycerol, pH 6.8) and ana- 
lyzed by SDS-PAGE. 
2.5. Western blotting 
Treatment of quiescent cultures of cells with factors, cell lysis and 
immunoprecipitations were performed as described above. After SDS- 
PAGE, immunoprecipitated proteins were transferred to Immobilon 
transfer membranes. Membranes were blocked using 5% non-fat dried 
milk in PBS, pH 7.2, and incubated for 2 h with either the ~125~~~ mAb 
or anti-Tyr(P) mAbs (Py20 and 4G10, 1 &ml of each antibody), as 
indicated, in PBS containing 3% non-fat dried milk. Immunoreactive 
bands were visualized using ‘ZSI-labeled sheep anti-mouse IgG followed 
by autoradiography. 
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Fig. 1. Effect of C3 exoenzyme pretreatment on bombesin-stimulated 
tyrosine phosphorylation of proteins and IOKIMARCKS phosphoryla- 
tion in Swiss 3T3 cells. (Upper panel) Cells pretreated in the presence 
(+C3) or absence (Cont.) of C3 exoenzyme were incubated with (B) or 
without (0) bombesin (1 nM) for 20 min at 37”C, lysed and the lysates 
immunoprecipitated with the anti-Tyr(P) mAb Py 72. Immunoprecipi- 
tates were analyzed by immunoblotting with anti-Tyr(P) mAbs (Py 20 
and 4GlO). The positions of molecular weight markers x lo-’ are 
shown on the left. Similar results were obtained in three independent 
experiments. (Lower panel) Cells pretreated with or without C3 exoen- 
zyme were further incubated for 12 hat 37°C in phosphate-free DMEM 
with 50 &Yml [-“PI Pi. Cells were subsequently stimulated either with 
(B) or without (0) bombesin (1 nM) for 20 min at 37”C, lysed and the 
lysates immunoprecipitated with IOK/MARCKS antisera and further 
analyzed by SDS-PAGE. 
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Fig. 2. Effect of C3 exoenzyme pretreatment on bombesin-stimulated 
tyrosine phosphorylation of ~125~~~ and paxillin in Swiss 3T3 cells. 
(Upper panel) Cells pretreated in the presence (+C3) or absence (-) of 
C3 exoenzyme were incubated with bombesin (1 nM) for 0, 1 or 20 min 
at 37°C or with 0,O.l or 1 nM bombesin for 20 min at 37”C, lysed and 
the lysates immunoprecipitated with the anti-p125FAK mAb 2A7. Im- 
munoprecipitates were analyzed by immunoblotting with anti-Tyr(P) 
mAbs. (Lower panel) Cells pretreated in the presence (+C3) or absence 
(-) of C3 exoenzyme were incubated with (B) or without (0) bombesin 
(1 nM) for 20 min at 37OC, lysed and the lysates immunoprecipitated 
with the anti-paxillin mAb 165. Immunoprecipitates were analyzed by 
immunoblotting with anti-Tyr(P) mAbs. 
2.6. 32P labeling of cells and analysis of SOKIMARCKS phosphorylation 
Quiescent and confluent cultures of Swiss 3T3 cells, previously incu- 
bated for 48 h in the presence or absence of the C3 exoenzyme (7.5 
pg/ml) were washed twice in phosphate-free DMEM and incubated at 
37’C with this medium containing 50 .&i/ml of carrier-free “Pi in the 
presence or absence of C3 exoenzyme (15 @ml). After 24 h the cells 
were stimulated with bombesin for 20 min. The cells were subsequently 
lysed as described above and the lysates were immunoprecipitated with 
an antiserum directed against 8OWMARCKS [23]. These immunopre- 
cipitates were further analysed by SDS-PAGE. 
2.7 Immunostaining of cells 
Following stimulation, cells were washed twice with PBS, fixed in 4% 
paraformaldehyde in PBS for 30 min at 4°C and permeabilized with 
PBS containing 0.2% Triton X-100 for 8 min at room temperature. The 
cells were then incubated with anti-Tyr(P) mAb (0.3 &ml) for 30 min 
at room temperature, subsequently washed three times in PBS and 
finally incubated with FITC-labeled anti-mouse IgG as a second anti- 
body at a dilution of 1: 100 for another 30 min at room temperature. 
Cells were visualised utilising a confocal microscope. 
2.8. Confocal microscopy 
Confocal imaging was performed using a Bio-Rad MRC-600 laser 
scanning head fitted onto a Nikon Optiphot microscope. A 60 x NA 
1.4 planapochromat oil immersion lens (Nikon) was used for all imag- 
ing. Fluorescein was elicited at 488 nm using a Krypton/Argon mixed 
gas laser (Bio-Rad). A Kl Iilter was used that is a double dichromic 
filter enabling excitation at 488 and 568 nm, and images were collected 
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using the Kalman filter. Data are presented as projections of sequential 
optical sections. For Z-series, optical sections were recorded at 0.3 pm. 
Final images were photographed directly from the VDU screen. 
2.9. Other methodr 
‘251-Labelled gastrin releasing peptide (GRP) binding [24], actin 
staining [14] and ADP ribosylation [22] were performed as described 
previously. 
3. Results and discussions 
To assess the role of rho p21 in the neuropeptide- stimulated 
tyrosine phosphorylation of specific proteins, cultures of Swiss 
3T3 cells were treated with the Clostridium botulinurn C3 exoen- 
zyme using a protocol that resulted in ADP ribosylation of rho 
p21 in intact cells (see section 2). This treatment of intact cells 
with recombinant C3 exoenzyme also caused a marked reduc- 
tion in actin stress fiber formation in response to bombesin 
(data not shown). 
The effect of C3 exoenzyme pretreatment on the tyrosine 
phosphorylation of proteins in Swiss 3T3 cells stimulated with 
1 nM bombesin for 20 min was examined. As shown in Fig. 1 
(upper panel) stimulation of these cells with bombesin induced 
tyrosine phosphorylation of two clusters of proteins migrating 
with an apparent h4, of llO,OOO-130,000 and 7O,OOC~80,000. 
Treatment of cells with the C3 exoenzyme caused a marked 
decrease in bombesin-mediated tyrosine phosphorylation of 
both bands. This result suggests that bombesin-stimulated ty- 
rosine phosphorylation of proteins depends on the activity of 
rho ~21. 
It was important to establish that the inhibitory effect of the 
C3 exoenzyme on bombesin-stimulated tyrosine phosphoryla- 
tion was specific. Bombesin and the structurally related mam- 
malian peptide GRP bind to a single class of high affinity 
receptors in Swiss 3T3 cells [2,24]. We verified that C3 exoen- 
zyme pretreatment had no effect on the specific binding of 
[izSI]GRP to Swiss 3T3 cells (data not shown). Furthermore, we 
examined the effect of the C3 exoenzyme pretreatment on 
bombesin- stimulated activation of protein kinase C (PKC) as 
measured by the phosphorylation of the specific PKC substrate 
80K/MARCKS [23,25]. The results shown in Fig. 1 (lower 
panel) indicate that C3 exoenzyme pretreatment of cells had no 
effect on bombesin-stimulated phosphorylation of 8OW 
MARCKS. Thus the inhibitory effects of the C3 exoenzyme are 
selective for the tyrosine phosphorylation pathway. 
The novel cytosolic tyrosine kinase ~125~~~ has been identi- 
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Fig. 3. Effect of C3 exoenzyme pretreatment on endothelin-stimulated changes in the actin cytoskeleton and anti-phosphotyrosine staining. Cells 
pretreated in the presence (+C3) or absence (Control) of C3 exoenzyme were incubated with (E) or without (0) endothelin (5 nM) for 20 min at 37°C. 
Cells were then washed with PBS, fixed in 4% paraformaldehyde, and permeabilized with 0.2% Triton X-100. Actin was stained by incubation in 
TRITC-conjugated phalloidin (0.25 &ml) in PBS for 10 min at room temperature. Immunostaining for phosphotyrosine was achieved using the 
specific anti-Tyr(P) mAb 4Gl0, followed by FITC-labeled anti-mouse IgG. Confocal imaging was performed as described in section 2. 
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Fig. 4. Effect of C3 exoenzyme pretreatment on endothelin-stimulated 
tyrosine phosphorylation of total proteins, ~125~~~ and paxillin in 
Swiss 3T3 cells. Cells pretreated in the presence (+C3) or absence (-) 
of C3 exoenzyme were incubated with (E) or without (0) endothelin 
(5 nM) for 20 min at 37’C, lysed and the lysates immunoprecipitated 
with either the anti-Tyr(P) mAb, Py 72 (upper panel), the anti-p125FAK 
mAb 2A7 or the anti-paxillin mAb 165 (lower panel). Immunoprecipi- 
tates were analyzed by immunoblotting with anti-Tyr(P) mAbs (Py 20 
and 4GlO). The autoradiogram of the anti-Tyr(P) immunoprecipitates 
is shown with the positions of molecular weight markers x 10e3 on the 
left. Autoradiograms of the anti-Tyr(P) immunoblots of ~125~~~ and 
paxillin immunoprecipitations were scanned with an LKB Ultrascan 
XL densitometer to quantify phosphoproteins in terms of peak area. 
Values correspond to the phosphorylation of either ~125~~~ or paxillin 
(as indicated) expressed as a percentage of the maximal response after 
subtraction of the control. 
fied as one of the prominent tyrosine phosphorylated proteins 
in born&in-treated Swiss 3T3 cells [ 111. As shown in Fig. 2, 
treatment of Swiss 3T3 cells with C3 exoenzyme reduced the 
increase in tyrosine phosphorylation of ~125~~~ as early as 
1 min after the addition of bombesin (55% inhibition). The 
decrease in ~125~~ tyrosine phosphorylation was comparable 
to that in cells treated with bombesin for 20 min. Tyrosine 
phosphorylation of p125FAK induced by various concentrations 
of bombesin was similarly inhibited by preincubation of cells 
in the presence of C3 exoenzyme (Fig. 2). 
Paxillin, a cytoskeletal-associated protein, has been identified 
as another major protein that is phosphorylated on tyrosine in 
response to bombesin [12]. This protein migrates on SDS- 
PAGE as a diffuse band with an apparent M, of 70,000-75,000. 
As is evident from Fig. I there is a striking reduction in the 
bombesin-stimulated tyrosine phosphorylation of this band in 
cells pretreated with C3 exoenzyme. Further, direct assessment 
of the tyrosine phosphorylation of paxillin using a specific 
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anti-paxillin mAb (mAb 165) demonstrated that pretreatment 
of cells with the C3 exoenzyme attenuated the increase in pax- 
illin tyrosine phosphorylation stimulated by bombesin. 
Endothelin, a neuropeptide that acts through a different G- 
protein-coupled receptor to bombesin, has previously been 
demonstrated to stimulate tyrosine phosphorylation of pro- 
teins, including p 1 25FAK and paxillin [3,11,12]. It is not known, 
however, whether endothelin, like bombesin [ 151, stimulates 
reorganisation of the actin cytoskeleton and the assembly of 
focal adhesion plaques in Swiss 3T3 cells. Examination of the 
actin cytoskeleton using TRITC-phalloidin revealed that endo- 
thelin stimulated striking actin stress fiber formation (Fig. 3). 
When cells were immunostained with anti-Tyr(P) mAbs it was 
evident that the proteins phosphorylated on tyrosine in re- 
sponse to endothelin were localized to small discrete patches at 
the periphery of the ventral membrane, consistent with focal 
adhesions (Fig. 3 ). Vinculin exhibited a very similar distribu- 
tion in endothelin-stimulated cells (results not shown). Pre- 
treatment of cells with C3 exoenzyme markedly reduced endo- 
thelin-stimulated actin stress fiber formation, redistribution of 
vinculin into focal contacts and tyrosine phosphorylation of 
proteins (Fig. 3 and data not shown). Western blot analysis was 
performed to determine the effect of C3 exoenzyme treatment 
on endothelin-stimulated tyrosine phosphorylation of specific 
proteins. As shown in Fig. 4 endothelin-stimulated tyrosine 
phosphorylation of M, 110,00&130,000 and 70,000-80,000 
proteins was inhibited in the C3 exoenzyme-treated cells. We 
also verified that C3 exoenzyme treatment attenuated the tyro- 
sine phosphorylation of ~125~~~ and paxillin induced by endo- 
thelin (Fig. 4). 
The results presented here demonstrate that C3 exoenzyme 
pretreatment, and consequent selective inactivation of rho p2 1, 
markedly inhibited neuropeptide-stimulated tyrosine phospho- 
rylation of multiple proteins, including ~125~~~ and paxillin, in 
Swiss 3T3 cells. These findings suggest hat rho p21 is a compo- 
nent of the signal transduction pathway linking neuropeptide 
receptors with tyrosine phosphorylation. The bioactive lipid, 
LPA, stimulates actin stress fiber formation and the tyrosine 
phosphorylation of a similar set of proteins as bombesin in 
Swiss 3T3 cells [26,27]. It has recently been shown that rho p21 
is critical for both these responses to LPA [15,22]. However, the 
putative cell surface receptor for LPA has not as yet been 
characterized and an intracellular mechanism of action has 
been postulated [28,29]. The results of this study suggest hat 
there is a common signal transduction pathway activated by 
seven transmembrane domain receptors, known to mediate the 
effects of bombesin and endothelin, in which rho p21 is up- 
stream of both cytoskeletal responses and the tyrosine phos- 
phorylation of specific proteins. 
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